Description
Introduction Of Holoxan 1gm Injection:
Holoxan 1gm Injection is a parenteral prescription medicine used to treat specific types of advanced cancers, such as certain soft tissue cancers and testicular cancer. It is a combination treatment designed both to target cancer cells and to protect your bladder from treatment-related irritation. Because it is highly specialised, it is always given under the supervision of an oncologist.
Since this medication is given as an injection, healthcare professionals will inject it in a clinical setting according to a strictly timed schedule. Staying well-hydrated and maintaining a balanced diet during your treatment cycle are essential lifestyle adjustments that help support your body and protect your kidneys. Your medical team will monitor your progress closely with regular blood and urine tests.
While receiving this treatment, you may experience common side effects like nausea, hair loss, or temporary fatigue. However, you must contact your doctor immediately if you experience serious symptoms such as blood in your urine, severe fever, or unusual bruising. Your healthcare team can provide supportive therapies to help manage these issues.
Do not take this if you have severe bladder inflammation, active urinary tract infections, or severe kidney damage. Before starting therapy, tell your doctor if you have a history of radiation therapy, liver damage, or low blood cell counts. Your medical team will evaluate these conditions to ensure the treatment is safe for you.
This medicine can interact with blood thinners and certain vaccines, which may increase your risk of bleeding or infections. Pregnant or breastfeeding women must not receive this medicine due to serious risks to the baby. Elderly individuals may require closer monitoring, particularly for kidney function and blood counts, to ensure safe use.
Uses Benefits Holoxan 1gm Injection:
Holoxan Uromitexan 1gm Injection is used to treat certain advanced cancers and help protect the bladder during chemotherapy. The detailed uses of Holoxan Uromitexan 1gm Injection are as follows:
- Testicular cancer
- Soft tissue sarcoma (cancer of the connective tissues)
- Lymphoma (cancer of the lymphatic system)
- Breast cancer
- Ovarian cancer
- Non-small cell lung cancer
- Prevention of bladder damage (hemorrhagic cystitis) caused by ifosfamide (with Uromitexan)
Benefits of Holoxan 1gm Injection:
1. Testicular cancer
When testicular cancer comes back or does not respond to the first treatment, ifosfamide is used with other chemotherapy medicines. It helps to destroy the cancer cells and improves the chance of keeping the disease under control.
2. Soft tissue sarcoma and lymphoma
These cancers begin in the connective tissues or in the lymph system. Ifosfamide damages the genetic material of the cancer cells, which stops them from dividing and helps to shrink the tumours.
3. Breast, ovarian, and lung cancers
In advanced stages of these cancers, ifosfamide may be added to a chemotherapy regimen to slow the growth and spread of the tumour. Your oncologist decides which medicines are best suited to your cancer type and stage.
4. Protection of the bladder
Ifosfamide produces a toxic by-product that can inflame and damage the bladder lining, leading to blood in the urine. Uromitexan (mesna), supplied in the same pack, binds to this substance in the urine and turns it into a harmless compound, which lowers the risk of this serious side effect and allows full chemotherapy doses to be given more safely.
Side Effects of Holoxan 1gm Injection:
Most side effects can be managed with the help of your treatment team. Consult your doctor if they persist or if you are worried about them.
Common side effects of Ifosfamide with Mesna:
- Nausea and vomiting
- Hair loss
- Low white blood cells, platelets, and red blood cells
- Increased risk of infections
- Pain or frequent need to urinate
- Blood in the urine
- Tiredness
- Drowsiness or confusion
- Unpleasant taste, headache, or diarrhea (with mesna)
Medium Of Action Of Holoxan 1gm Injection:
Holoxan 1gm Injection with Uromitexan Injection is a combination of a chemotherapy medicine and a bladder-protecting medicine. Ifosfamide is an alkylating agent that the liver changes into its active forms, and these attach to the DNA of cancer cells and join its strands together. The cells can no longer copy their DNA or divide, so they die. In the process, ifosfamide also produces a toxic substance called acrolein, which can harm the bladder. Mesna reacts with acrolein in the urine and forms a stable, harmless compound, and it does not interfere with the anticancer action of ifosfamide. This is how the pack fights cancer and protects the bladder.
Reviews
There are no reviews yet.